Press Releases

Mast Therapeutics Reports First Quarter 2013 Financial Results
May 15, 2013
Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
April 17, 2013
Mast Therapeutics Engages ESC Advisors To Identify Partnering Opportunities For MST-188
March 28, 2013
European Commission Designates MST-188 As An Orphan Medicinal Product
March 25, 2013
Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
March 19, 2013
ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
March 11, 2013
ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
February 28, 2013
Adventrx To Develop ANX-188 For Complications Of Arterial Disease
February 28, 2013

Follow Us! >>